Pathogenesis and pathogenetic options in endometriosis management

М.Р. Оразов, V.E. Radzinsky, Evgeny D. Dolgov, Yu.G. Abramashvili
In: Voprosy ginekologii, akušerstva i perinatologii · 2023 · vol. 22(1) , pp. 92–104 · doi:10.20953/1726-1678-2023-1-92-104 · W4360593102
Review OA: closed CC0 ⤵ 3 in-corpus citations
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This review examines the etiopathogenesis, genetic and molecular determinants of endometriosis, and substantiates the use of dienogest for conservative management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text ⓘ

This 2023 article is a literature review focused on the etiopathogenesis of endometriosis, with particular emphasis on genetic and molecular biological determinants. It also discusses conservative management approaches for patients with confirmed endometriosis. The authors specifically substantiate the use of dienogest as a therapeutic option within this management context. This paper is centrally about endometriosis — it reviews endometriosis pathogenesis and supports dienogest in conservative management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This article provides a literature review on the etiopathogenesis of endometriosis. Particular attention was paid to genetic and molecular biological aspects of endometriosis. The issues of conservative management of patients with confirmed endometriosis were also considered. The use of dienogest in the treatment of patients with endometriosis was substantiated. Key words: endometriosis, etiopathogenesis, genetic and molecular determinants, dienogest
Full text 893 characters · extracted from oa-doi-fallback · click to expand
Pathogenesis and pathogenetic options in endometriosis management Mekan R.Orazov / Victor E. Radzinsky / Evgenii D. Dolgov / Yulia G. Abramashvili / This article provides a literature review on the etiopathogenesis of endometriosis. Particular attention was paid to genetic and molecular biological aspects of endometriosis. The issues of conservative management of patients with confirmed endometriosis were also considered. The use of dienogest in the treatment of patients with endometriosis was substantiated. Key words: endometriosis, etiopathogenesis, genetic and molecular determinants, dienogest For citation: Orazov M.R., Radzinsky V.E., Dolgov E.D., Abramashvili Yu.G. Pathogenesis and pathogenetic options in endometriosis management. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2023; 22(1): 92–104. (In Russian). DOI: 10.20953/1726-1678-2023-1-92-104

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK